Health & Fitness
Health and Fitness
Health and Fitness
Wed, December 31, 2008
Tue, December 30, 2008
Mon, December 29, 2008 Micrus Endovascular to Present at the 11th Annual Needham Growth Stock Conference
SAN JOSE, Calif.--([ BUSINESS WIRE ])--Micrus Endovascular Corporation (NASDAQ:MEND) today announced that John Kilcoyne, Chairman and CEO, will present at the 11th Annual Needham Growth Stock Conference on Tuesday, January 6, 2009, at 11:30 a.m. Eastern time (8:30 a.m. Pacific time), which will be held at the New York Palace Hotel.
A live webcast of the conference presentation will be available via the Internet by visiting the Investor Relations section of Micrus' Web site at [ www.micruscorp.com ]. An archive of the presentation will be available on the Web site for 14 days.
About Micrus Endovascular Corporation
Micrus develops, manufactures and markets implantable and disposable medical devices for use in the treatment of cerebral vascular diseases. Micrus products are used by interventional neuroradiologists, interventional neurologists and neurosurgeons to treat both cerebral aneurysms responsible for hemorrhagic stroke and intracranial atherosclerosis, which may lead to ischemic stroke. Hemorrhagic and ischemic stroke are both significant causes of death and disability worldwide. The Micrus product line enables physicians to gain access to the brain in a minimally invasive manner through the vessels of the arterial system. Micrus' proprietary, three-dimensional microcoils automatically deploy within the aneurysm, forming a scaffold that conforms to a wide diversity of aneurysm shapes and sizes. Micrus also sells access devices such as guide catheters, microcatheters and accessory products used in conjunction with its microcoils. For more information, visit [ www.micruscorp.com ].
